InvestSMART

Radiopharm Theranostics Limited (ASX: RAD) - Announcements

Current share price for RAD : $0.005 0.001 (25%)+

ASX company news and announcements for Radiopharm Theranostics Limited (RAD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Radiopharm Theranostics Limited (RAD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Radiopharm Theranostics Limited (RAD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Radiopharm Theranostics Limited (RAD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 4:34PM $0.005 $0.005 fallen by 0%
$24 Notice of Annual General Meeting/Proxy Form 27 Oct 2026 11:54AM $0.004 $0.005 risen by 25%
$24 Radiopharm receives $8M advance on FY26 R&D tax incentive 26 Oct 2026 3:53PM $0.005 $0.005 risen by 11.11%
$24 Notification regarding unquoted securities - RAD 20 Oct 2026 3:52PM $0.005 $0.005 risen by 11.11%
$24 Change of Director's Interest Notices x 4 20 Oct 2026 3:46PM $0.005 $0.005 risen by 11.11%
$24 Notification of cessation of securities - RAD 20 Oct 2026 3:19PM $0.005 $0.005 risen by 11.11%
$24 Non-Compliance with Listing Rule 10.11 12 Oct 2026 12:32PM $0.005 $0.005 fallen by 0%
$24 RAD Completes Meeting with US FDA for Development of RAD101 5 Oct 2026 8:40AM $0.007 $0.005 fallen by 28.57%
$24 Notification of cessation of securities - RAD 1 Oct 2026 4:21PM $0.006 $0.005 fallen by 16.67%
$24 Change of Director's Interest Notice (RC) 1 Oct 2026 4:18PM $0.006 $0.005 fallen by 16.67%
$24 Appendix 4G and Corporate Governance Statement 30 Sep 2026 4:24PM $0.006 $0.005 fallen by 16.67%
$24 Annual Report and Form 20-F 30 Sep 2026 4:18PM $0.006 $0.005 fallen by 16.67%
$24 Change of Director's Interest Notices x 4 22 Sep 2026 2:13PM $0.008 $0.005 fallen by 37.50%
$24 Notification regarding unquoted securities - RAD 17 Sep 2026 10:47AM $0.008 $0.005 fallen by 33.33%
$24 RADOC New Class Options Range of Units and Top 20 Holders 17 Sep 2026 10:41AM $0.008 $0.005 fallen by 33.33%
$24 Application for quotation of securities - RAD 17 Sep 2026 10:37AM $0.008 $0.005 fallen by 33.33%
$24 Application for quotation of securities - RAD 17 Sep 2026 10:30AM $0.008 $0.005 fallen by 33.33%
$24 Share purchase plan completed 17 Sep 2026 10:11AM $0.008 $0.005 fallen by 33.33%
$24 RAD oral presentation at SNO26 on RAD101 Phase IIb data 14 Sep 2026 8:54AM $0.008 $0.005 fallen by 37.50%
$24 Results of Meeting 11 Sep 2026 12:35PM $0.009 $0.005 fallen by 44.44%
$24 RAD Announces Positive Data from RAD301 P1 Imaging Trial 9 Sep 2026 9:21AM $0.009 $0.005 fallen by 44.44%
$24 Appendix 4E and Preliminary Final Report 28 Aug 2026 4:07PM $0.009 $0.005 fallen by 44.44%
$24 Change of Director's Interest Notices x 4 27 Aug 2026 2:50PM $0.010 $0.005 fallen by 50%
$24 RAD Doses First Patient in Second Cohort of BetaBart (RV-01) 26 Aug 2026 8:59AM $0.011 $0.005 fallen by 52.38%
$24 Ceasing to be a substantial holder 24 Aug 2026 4:43PM $0.011 $0.005 fallen by 54.55%

1 - 25 of 638 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.